NCT03141177 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 323
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 328
- group Id
- BG003
- value
- 701
- units
- Participants
- groups
- description
- Nivolumab 240 mg flat dose IV Q2W + Cabozantinib 40 mg PO QD
- id
- BG000
- title
- Treatment A
- description
- Nivolumab 3 mg/kg IV Q3W (x4 doses) + Cabozantinib 40 mg PO QD + Ipilimumab 1 mg/kg IV Q3W (x4 doses) Then Nivolumab 240 mg flat dose IV Q2W + Cabozantinib 40 mg PO QD
- id
- BG001
- title
- Treatment B
- description
- Sunitinib 50 mg PO QD for 4 weeks, followed by 2 weeks off, per cycle
- id
- BG002
- title
- Treatment C
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.2
- value
- 61.4
- group Id
- BG001
- spread
- 9.5
- value
- 60.3
- group Id
- BG002
- spread
- 10.6
- value
- 60.4
- group Id
- BG003
- spread
- 10.4
- value
- 60.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 96
- group Id
- BG003
- value
- 186
- title
- Female
- measurements
- group Id
- BG000
- value
- 249
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 232
- group Id
- BG003
- value
- 515
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 90
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 149
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 151
- group Id
- BG003
- value
- 319
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 136
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 138
- group Id
- BG003
- value
- 292
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 5
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 25
- group Id
- BG003
- value
- 51
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 5
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 267
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 266
- group Id
- BG003
- value
- 576
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 64
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 323
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 328
- group Id
- BG003
- value
- 701
- units
- Participants
- groups
- description
- Nivolumab 240 mg flat dose IV Q2W + Cabozantinib 40 mg PO QD
- id
- BG000
- title
- Treatment A
- description
- Nivolumab 3 mg/kg IV Q3W (x4 doses) + Cabozantinib 40 mg PO QD + Ipilimumab 1 mg/kg IV Q3W (x4 doses) Then Nivolumab 240 mg flat dose IV Q2W + Cabozantinib 40 mg PO QD
- id
- BG001
- title
- Treatment B
- description
- Sunitinib 50 mg PO QD for 4 weeks, followed by 2 weeks off, per cycle
- id
- BG002
- title
- Treatment C
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.2
- value
- 61.4
- group Id
- BG001
- spread
- 9.5
- value
- 60.3
- group Id
- BG002
- spread
- 10.6
- value
- 60.4
- group Id
- BG003
- spread
- 10.4
- value
- 60.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 96
- group Id
- BG003
- value
- 186
- title
- Female
- measurements
- group Id
- BG000
- value
- 249
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 232
- group Id
- BG003
- value
- 515
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 90
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 149
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 151
- group Id
- BG003
- value
- 319
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 136
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 138
- group Id
- BG003
- value
- 292
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 5
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 25
- group Id
- BG003
- value
- 51
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 5
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 267
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 266
- group Id
- BG003
- value
- 576
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 64
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle